First Time Loading...
C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 1.75 AUD Market Closed
Updated: Apr 29, 2024

Cyclopharm Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cyclopharm Ltd
Cash from Financing Activities Peer Comparison

Comparables:
NTI
IPD
COH
OIL
EMV

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
C
Cyclopharm Ltd
ASX:CYC
Cash from Financing Activities
-AU$1m
CAGR 3-Years
-1%
CAGR 5-Years
-24%
CAGR 10-Years
2%
Neurotech International Ltd
ASX:NTI
Cash from Financing Activities
AU$9.4m
CAGR 3-Years
250%
CAGR 5-Years
23%
CAGR 10-Years
N/A
ImpediMed Ltd
ASX:IPD
Cash from Financing Activities
AU$28m
CAGR 3-Years
3%
CAGR 5-Years
192%
CAGR 10-Years
N/A
Cochlear Ltd
ASX:COH
Cash from Financing Activities
-AU$377.1m
CAGR 3-Years
N/A
CAGR 5-Years
-9%
CAGR 10-Years
-21%
Optiscan Imaging Ltd
ASX:OIL
Cash from Financing Activities
AU$16.2m
CAGR 3-Years
21%
CAGR 5-Years
140%
CAGR 10-Years
54%
EMvision Medical Devices Ltd
ASX:EMV
Cash from Financing Activities
AU$2.5m
CAGR 3-Years
-16%
CAGR 5-Years
8%
CAGR 10-Years
N/A

See Also

What is Cyclopharm Ltd's Cash from Financing Activities?
Cash from Financing Activities
-1m AUD

Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Cash from Financing Activities amounts to -1m AUD.

What is Cyclopharm Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
2%

Over the last year, the Cash from Financing Activities growth was -40%. The average annual Cash from Financing Activities growth rates for Cyclopharm Ltd have been -1% over the past three years , -24% over the past five years , and 2% over the past ten years .